First AD

Second AD

Understanding Prostate-Specific Antigen (PSA) Testing

Video content above is prompted by the following:

What is a PSA test and how is it performed? How do PSA levels guide next steps? 

Can you explain what high-risk and advanced prostate cancer are, eg, (non-metastatic castration-sensitive prostate cancer (nmCSPC) with BRC at high risk for metastases, castration-resistant prostate cancer (CRPC), and metastatic CSPC (mCSPC)? What is the prognosis for patients diagnosed with advanced disease?

Managing Advanced Prostate Cancer: Treatment Landscape, Patient Care, and Quality of Life 

Receiving a cancer diagnosis is life-altering. Although every situation is unique, the emotional experience and need for guidance and support is universal. You will undoubtedly have many questions and concerns. At CURE, we recognize the power of information and community. Our medical experts, patient guests, caregivers, and family members featured on CURE Connections® are here to share their insights based on their own knowledge and experiences.

CURE Connections 

Prostate cancer screening is crucial for early detection and management, particularly in high-risk groups such as men over 50, African American men, and those with a family history of the disease. Routine screening, including PSA tests and digital rectal exams, can help identify cancer at an early, more treatable stage. Decisions about screening should be individualized, considering the patient's risk factors and overall health. Symptoms like urinary issues or family history often prompt individuals to seek screening, but routine checks are vital for asymptomatic individuals to catch potential issues early.

Panelists discuss how the PSA test is conducted and interpreted, and clarify the definitions of high-risk and advanced prostate cancer types, including their implications for prognosis and subsequent treatment decisions.

Understanding Prostate-Specific Antigen (PSA) Testing

Latest News